GT health — Wise Endocrine & Metabolic Care

Patient MessagingPatients

A 3D-rendered thyroid gland with visible cancerous nodules appears in the center of a modern operating room. Surgical lights and medical equipment surround the scene, highlighting a clinical setting. The image represents thyroid cancer diagnosis or treatment, emphasizing thyroid care in Maryland.

Understanding Thyroid Cancer

Thyroid cancer develops when abnormal cells grow in the thyroid, a small, butterfly-shaped gland in the lower front of the neck. This gland plays a crucial role in regulating metabolism, energy levels, and hormone balance. While thyroid cancer remains less common than other cancers, its incidence has been rising since 1992, partly due to improved imaging techniques that detect small, asymptomatic tumors.

In the United States, about 44,000 new thyroid cancer cases are diagnosed each year, with the majority occurring in women. It is three times more common in women than men and is typically detected between the ages of 30 and 60. Despite its increasing prevalence, most thyroid cancers have an excellent prognosis, particularly when detected and treated early with a personalized approach.

At my Montgomery County, Maryland practice, I focus on holistic, individualized thyroid care, considering not just the cancer itself but also metabolic health, hormonal balance, and long-term well-being. Patients with thyroid concerns benefit from a comprehensive evaluation that goes beyond standard protocols to ensure the best possible outcome.

Types of Thyroid Cancer

  1. Papillary Thyroid Cancer (PTC): Papillary thyroid cancer is the most common type, accounting for about 80% of all thyroid cancer cases. It tends to grow slowly and remains confined to the thyroid or nearby lymph nodes. Even when it spreads, it responds well to treatment, with a 10-year survival rate exceeding 95%. Holistic thyroid management, including nutritional guidance, hormone balance, and long-term monitoring, ensures optimal recovery.
  2. Follicular Thyroid Cancer (FTC): Follicular thyroid cancer represents 10-15% of cases and is more likely than papillary cancer to spread to the lungs or bones. It is more common in iodine-deficient regions, highlighting the role of nutritional and metabolic health in thyroid function. Personalized iodine assessment and tailored supplementation play an important role in prevention and post-treatment support.
  3. Medullary Thyroid Cancer (MTC): Medullary thyroid cancer comprises 3-4% of thyroid cancers and originates from the C cells of the thyroid, which produce calcitonin. Unlike other types, MTC is often linked to genetic mutations in the RET proto-oncogene, making genetic screening essential. Holistic endocrine evaluation can help optimize calcium regulation and long-term metabolic balance in patients with this condition.
  4. Anaplastic Thyroid Cancer (ATC): Anaplastic thyroid cancer is rare, making up less than 2% of cases, but is the most aggressive form. It often spreads rapidly to surrounding tissues and distant organs, making early detection and multidisciplinary care essential. A comprehensive approach integrating advanced treatments, nutritional strategies, and immune support may enhance quality of life in affected patients.

Causes and Risk Factors

Thyroid cancer develops due to genetic mutations that drive uncontrolled cell growth. Several risk factors contribute to its onset:

  • Radiation exposure, particularly childhood radiation therapy or environmental exposure, significantly increases the risk. Patients exposed to the Chernobyl nuclear disaster developed a marked increase in thyroid cancer cases.
  • Genetic predisposition plays a key role, particularly in medullary thyroid cancer (MTC). Genetic counseling is important for patients with a family history of thyroid malignancies.
  • Iodine deficiency or excess impacts thyroid health. A personalized iodine assessment is crucial to prevent conditions that may promote malignancy.
  • Hormonal influences, particularly estrogen exposure, may explain why thyroid cancer is three times more common in women than men. Hormonal optimization is an essential part of holistic thyroid care.
  • Pre-existing thyroid conditions such as Hashimoto’s thyroiditis and Grave’s disease may increase cancer risk. Addressing autoimmune triggers, inflammation, and metabolic imbalances can improve thyroid resilience.

Recognizing Symptoms

Thyroid cancer is often silent in early stages. The most common symptom is a painless lump or swelling in the neck. Other symptoms include:

  • Hoarseness or persistent voice changes.
  • Difficulty swallowing or breathing.
  • Enlarged lymph nodes.
  • A persistent cough without a clear cause.
  • Neck pain that may radiate to the ears.

Since many of these symptoms overlap with benign thyroid nodules, a thorough, personalized thyroid assessment is essential for an accurate diagnosis.


Thyroid Cancer Diagnosis

  1. Thorough Clinical Examination: A comprehensive thyroid evaluation begins with a detailed ultrasound to assess the thyroid’s structure and blood flow. Ultrasound characteristics can detect high-risk nodules before they become symptomatic.
  2. Fine Needle Aspiration (FNA) Biopsy: A fine needle biopsy extracts thyroid cells for microscopic examination. In cases of indeterminate biopsy results, additional molecular testing can provide clarity and prevent unnecessary surgery.
  3. Advanced Molecular and Genetic Testing: For nodules with inconclusive biopsy results, genetic mutation analysis helps determine cancer risk. BRAF, RAS, and RET testing provides insights that guide individualized treatment plans.
  4. Metabolic and Hormonal Testing: While thyroid cancer often does not affect TSH or thyroid hormone levels, a full metabolic assessment helps optimize thyroid health. Assessing iodine, selenium, and inflammatory markers ensures a whole-body approach to treatment.

Personalized Thyroid Cancer Treatment

  1. Surgery with Functional Thyroid Considerations: Surgical removal of the thyroid (thyroidectomy) is the primary treatment for most thyroid cancers. However, in low-risk cases, a lobectomy may be an alternative to preserve some thyroid function. Preserving parathyroid glands and optimizing calcium balance is a critical aspect of holistic post-surgical care.
  2. Radioactive Iodine (RAI) Therapy and Nutritional Support: For papillary and follicular thyroid cancer, radioactive iodine therapy (RAI) eliminates residual thyroid cells. A low-iodine diet before treatment enhances effectiveness. Personalized post-RAI nutritional plans help patients recover metabolic balance.
  3. Thyroid Hormone Optimization: After thyroid removal, patients require lifelong thyroid hormone replacement (levothyroxine). TSH suppression therapy is often used to prevent recurrence. A personalized hormone regimen ensures optimal metabolic function and energy levels.
  4. Targeted Therapy and Holistic Support: For advanced or resistant thyroid cancers, new treatments like tyrosine kinase inhibitors (TKIs) provide improved survival rates. Nutritional strategies, immune support, and metabolic therapies complement conventional treatment and enhance quality of life.

Long-Term Holistic Thyroid Care

With a high survival rate, most thyroid cancer patients live long, healthy lives. However, personalized monitoring and support are crucial.

  • Regular thyroglobulin testing helps detect recurrence early.
  • Ongoing ultrasound surveillance ensures that the thyroid bed remains cancer-free.
  • Metabolic and nutritional assessments optimize long-term thyroid function.

At my Montgomery County, Maryland practice, I provide individualized, holistic thyroid care that integrates medical treatments, metabolic optimization, and long-term thyroid health strategies. If you have concerns about your thyroid, a personalized evaluation can help ensure the best possible outcome.

Dr. Tashko

Logo for Endocrine ABIM board-certified.

References:

  1. 2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Haugen BR, Alexander EK, Bible KC, et al. Thyroid : Official Journal of the American Thyroid Association. 2016;26(1):1-133. doi:10.1089/thy.2015.0020.
  2. SNMMI Procedure Standard/­Eanm Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version. Avram AM, Giovanella L, Greenspan B, et al. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 2022;63(6):15N-35N.
  3. Diagnosis of Thyroid Nodules. Alexander EK, Cibas ES. The Lancet. Diabetes & Endocrinology. 2022;10(7):533-539. doi:10.1016/S2213-8587(22)00101-2.
  4. Thyroid Nodules. Burman KD, Wartofsky L. The New England Journal of Medicine. 2015;373(24):2347-56. doi:10.1056/NEJMcp1415786.
  5. Thyroid Cancer: A Review. Boucai L, Zafereo M, Cabanillas ME., Jama. 2024;331(5):425-435. doi:10.1001/jama.2023.26348.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is a board-certified endocrinologist based in Montgomery County, Maryland. He is uniquely certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice offers comprehensive, root-cause-focused metabolic and endocrine care, available both virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to optimize long-term health outcomes.